ECVT Ecovyst Inc.
Chemicals & Allied Products · NYSE · SEC CIK 1708035 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY44.6%
TTM net income YoY133.6%
TTM EPS YoY134.4%
Revenue 3-yr CAGR11.5%
Net income 3-yr CAGR-18.4%
Margins
Gross margin19.7%
Operating margin8.5%
Net margin3.7%
FCF margin2.8%
EBITDA margin15.9%
Returns
ROE5.9%
ROA2.3%
ROIC (approx.)5.4%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets57.2%
Debt / equity0.81x
Current ratio1.82x
Interest coverage3.73x
Cash quality & payout
Operating cash flow / net income3.28x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue9.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $723.51M | $598.29M | $584.85M | $820.16M | $611.20M |
| Cost of revenue | $565.43M | $434.91M | $418.40M | $595.53M | $434.54M |
| Gross profit | $158.09M | $163.38M | $166.45M | $224.63M | $176.66M |
| R&D expense | — | $6.81M | $7.80M | $7.23M | $7.50M |
| SG&A expense | $66.02M | $65.39M | $60.53M | $85.33M | $97.78M |
| Operating income | $64.89M | $85.13M | $89.55M | $104.39M | $54.61M |
| Interest expense | $34.20M | $36.49M | $31.70M | $37.22M | $36.99M |
| Pretax income | $25.79M | $45.20M | $56.95M | $94.73M | $13.94M |
| Income tax | $19.50M | -$299,000 | $8.73M | $24.94M | $12.15M |
| Net income | -$71.13M | -$6.65M | $71.15M | $73.70M | -$139.95M |
| EBITDA | $132.69M | $145.00M | $144.90M | $183.55M | $134.35M |
| EPS (basic) | -0.62 | -0.06 | 0.60 | 0.55 | -1.03 |
| EPS (diluted) | -0.61 | -0.06 | 0.60 | 0.55 | -1.02 |
| Dividends declared per share | — | — | — | — | 3.20 |
| Weighted avg. shares (diluted) | 115.96M | 117.45M | 119.49M | 135.09M | 137.71M |
| Balance sheet | |||||
| Cash & equivalents | $197.19M | $131.39M | $72.65M | $110.92M | $140.89M |
| Receivables | $85.31M | $53.20M | $81.31M | $74.76M | $80.80M |
| Inventory | $26.80M | $17.97M | $45.12M | $44.36M | $53.81M |
| Current assets | $319.36M | $303.71M | $245.99M | $267.70M | $291.67M |
| PP&E, net | $481.16M | $458.68M | $576.90M | $584.89M | $596.23M |
| Goodwill | $326.74M | $326.59M | $404.47M | $403.16M | $406.14M |
| Intangibles | $59.29M | $67.70M | $116.55M | $129.93M | $145.62M |
| Total assets | $1.26B | $1.80B | $1.84B | $1.88B | $1.93B |
| Current liabilities | $120.81M | $115.13M | $119.08M | $129.40M | $145.08M |
| Short-term debt | $0 | $8.73M | $9.00M | $9.00M | $9.00M |
| Long-term debt | $392.58M | $852.10M | $858.95M | $865.87M | $872.84M |
| Total debt | $392.58M | $860.83M | $867.95M | $874.87M | $881.84M |
| Total liabilities | $657.54M | $1.10B | $1.13B | $1.18B | $1.19B |
| Shareholders' equity | $603.44M | $700.46M | $705.46M | $707.23M | $740.74M |
| Net debt | $195.39M | $729.44M | $795.30M | $763.95M | $740.95M |
| Shares outstanding | 111.81M | 116.53M | 116.12M | 122.19M | 136.94M |
| Cash flow statement | |||||
| Operating cash flow | $140.31M | $149.89M | $137.60M | $186.61M | $129.92M |
| Capital expenditure | $70.41M | $55.59M | $59.04M | $58.87M | $60.05M |
| Free cash flow | $69.89M | $94.30M | $78.56M | $127.74M | $69.87M |
| Investing cash flow | $435.41M | -$73.45M | -$65.33M | -$63.02M | $835.73M |
| Financing cash flow | -$524.96M | -$17.84M | -$93.50M | -$148.19M | -$964.23M |
| Depreciation & amortization | $67.81M | $59.86M | $55.34M | $79.16M | $79.74M |
| Stock-based compensation | $9.75M | $11.13M | $12.98M | $20.63M | $31.84M |
| Dividends paid | — | — | $0 | $0 | $435.59M |
| Share buybacks | $46.95M | $5.01M | $78.72M | $136.74M | $0 |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.